| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SERTM1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | HRH3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | NPIPB4 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | EVI2A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RP11-468E2.6 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | CFAP53 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SLC29A4 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | SAGE1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | NAT6 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | TTC23L | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
